Navigation Links
Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent, Safe Topical Anti-Androgens
Date:7/20/2009

be sufficient to obtain FDA approval. There can be no assurance that any product in the combined company's product pipeline will be successfully developed or manufactured, that final results of clinical studies will be supportive of regulatory approvals required to market licensed products, or that any of the forward-looking information provided herein will be proven accurate. Additional important factors and product information that may affect future results are available at http://www.hygeiatherapeutics.com

Hygeia disclaims any intent or obligation to update these forward-looking statements beyond the date of this release. This caution is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

SOURCE: Hygeia Therapeutics Inc.
Hygeia Therapeutics Inc.
Yael Schwartz, PhD, President and CEO
774-242-1135

###

Read the full story at http://www.prweb.com/releases/2009/07/prweb2656424.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Nile Therapeutics, Inc. Completes $3.4 Million Private Placement
2. Oxygen Biotherapeutics, Inc. Announces Closing of Private Placement Financing Agreement
3. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments
4. Nile Therapeutics, Inc. To Raise $3.4 Million in Private Placement
5. New Report Just Published: World Prostate Cancer Therapeutics Market Report
6. King and Pain Therapeutics Announce REMOXY(R) NDA Update
7. Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes
8. Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma
9. Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
10. PTC Therapeutics Receives $2.6 Million in Government Grants
11. Cell Therapeutics on Preliminary List of Additions to Russell 3000(R) Index and Russell Global(R) Index

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., CARY,N.C.,Nov.23/PRNewswire-FirstCall/--Cor...pharmaceuticalcompanyfocusedonacquiring,developing...herespiratoryandrelatedmarkets,todayannouncedthatC...llbepresentingacorporateoverviewatthe21stAnnualPip...,December2,2009atTheNewYorkPalaceHotelinNewYorkCit...
(Date:11/20/2009)..., , ROCKVILLE, Md., Nov. 20 /PRNewswire-Fi...nnounced that it has priced an underwritten public...at a price to the public of $3.30 per share. The ...educting the underwriting discounts and commission...al trials of our VLP-based vaccines, internal rese...
(Date:11/19/2009)..., Most people would like to be able to charge the...kly and not too often. A recent discovery made by ...be-based supercapacitors that could do just this. ...sics Letters , Prabhakar Bandaru, a professor in t...ineering, along with graduate student Mark Hoefer,...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 /PRNewswire-FirstCall/...day that it has sent the following letter to its s... on October 30, 2009, of China Biopharmaceuticals ...tical company based in the People,s Republic of Ch...terest in Suzhou Eyre Pharmaceutical Co. Ltd., CHB...
Breaking Biology Technology:Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Novavax Prices Public Offering of Common Stock 2Nanotube defects equal better energy and storage systems 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...ceives Approval from Chinese Health Authorities to...or Asacard(R), NEW HAVEN, Conn., Aug. 25 RHEI Ph...t of Dr. Geert Cauwenbergh as Chief Executive,Offi...cently passed away.,Dr Cauwenbergh has been assist...roviding the necessary leadership to continue the ...
...ESENTS AT THOMAS WEISEL WEDNESDAY, SEPTEMBER 3RD A...ENCE THURSDAY, SEPTEMBER 4TH, SAN DIEGO, Aug. 25 ...unced today that Kevin Gorman, President and Chief...Thomas Weisel Healthcare,Conference in Boston and ...in New York., The presentation at the Thomas Weis...
...TY, Calif. and MUMBAI, India, Aug. 25 ,Codexis, In...Pharmalabs,Limited, a leading Indian active pharma...facturer, today announced a major new strategic,co...p in pharmaceuticals,manufacturing., Codexis, bas...ceutical,intermediates and active pharmaceutical i...
Other Biology Technology:RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer 2RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer 3RHEI Pharmaceuticals Appoints Dr. Geert Cauwenbergh as Chief Executive Officer 4Neurocrine Biosciences to Present at Thomas Weisel Healthcare Conference and the NewsMakers in the Biotech Industry Conference 2Codexis, Arch Announce Expanded Collaboration 2Codexis, Arch Announce Expanded Collaboration 3
(Date:11/20/2009)...ited to contribute their abstracts to the World Co...e largest global meeting devoted to all aspects of...ent care. The Congress will be held in Florence, I...racts can be submitted online at http://www.iofwc...ruary 4, 2010. , IOF and ESCEO are pleased to an...
(Date:11/20/2009)...., November 19, 2009 The estimated 4.6 million Am...risk of developing respiratory symptoms due to poo...ionnaire study undertaken earlier this year by inv...f Veterinary Medicine. , The studywhich polled m...at 50 percent of individuals working in barns comp...
(Date:11/20/2009)...9th 2009 - Bacteria possess an ingenious mechanism...locks of the cell. This is the new finding of a te...B, a life sciences research institute in Flanders,...sel. The scientists made this discovery by modifyi...a coli . By means of this model organism, they hav...
Breaking Biology News(10 mins):Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3Barn personnel experience higher-than-average rates of respiratory symptoms 2Biologists discover bacterial defense mechanism against aggressive oxygen 2Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2Media Alert 3A July 10 Run Miles for Special Smiles 47691 1Media Alert 3A July 10 Run Miles for Special Smiles 47691 2Diplomat Specialty Pharmacy Promotes Rinku A Patel PharmD to Vice President Pharmacy Strategy 47686 1Diplomat Specialty Pharmacy Promotes Rinku A Patel PharmD to Vice President Pharmacy Strategy 47686 2
...he idea is to teach the immune system of children ... insulin-producing cells of the pancreas. , "We w...r, immunologist who directs the Medical College of...classified as an autoimmune disease because the im...ction, leaving young patients unable to use glucos...
... available in Spanish . , CAREFREE, A.Z. - Dat...l be released for the first time at the American A...cience of Cancer Health Disparities in Carefree, A...ority group in the United States, but little is kn...a Martinez, Ph.D., professor of epidemiology at Th...
...d. -- Scientists have recovered fossils from a 60-... and weight might make today,s anacondas and retic... Named Titanoboa cerrejonensis by its discovere...eighed 1,140 kilograms (2,500 pounds) and measured...t,s a conservative estimate. A report describing t...
Other Biology News:Molecule that suppresses immune response under study in type 1 diabetes 2Molecule that suppresses immune response under study in type 1 diabetes 3Hispanic women and breast cancer: An understudied group 2Hispanic women and breast cancer: An understudied group 3Hispanic women and breast cancer: An understudied group 4At 2,500 pounds and 43 feet, prehistoric snake is the largest on record 2At 2,500 pounds and 43 feet, prehistoric snake is the largest on record 3
QuantiGene Plex Reagent Set for Animal/Plant Tissue from Panomics
Rabbit Anti-Occludin, C-Terminus Monoclonal Antibody, GST Conjugated, Clone PADZMD.544 from Invitrogen
Mouse Anti-JNK2 Antibody, Unconjugated from Upstate
ProtoArray Kinase Substrate Identification Application Kit from Invitrogen
Biology Products: